112 related articles for article (PubMed ID: 26565618)
1. Oligomycins as inhibitors of K-Ras plasma membrane localisation.
Salim AA; Tan L; Huang XC; Cho KJ; Lacey E; Hancock JF; Capon RJ
Org Biomol Chem; 2016 Jan; 14(2):711-715. PubMed ID: 26565618
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33
Lysenkova LN; Saveljev OY; Omelchuk OA; Zatonsky GV; Korolev AM; Grammatikova NE; Bekker OB; Danilenko VN; Dezhenkova LG; Mavletova DA; Scherbakov AM; Shchekotikhin AE
Nat Prod Res; 2020 Nov; 34(21):3073-3081. PubMed ID: 31075992
[TBL] [Abstract][Full Text] [Related]
3. Rare Streptomyces sp. polyketides as modulators of K-Ras localisation.
Salim AA; Xiao X; Cho KJ; Piggott AM; Lacey E; Hancock JF; Capon RJ
Org Biomol Chem; 2014 Jul; 12(27):4872-8. PubMed ID: 24875924
[TBL] [Abstract][Full Text] [Related]
4. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth.
Tan L; Cho KJ; Neupane P; Capon RJ; Hancock JF
J Biol Chem; 2018 Aug; 293(35):13696-13706. PubMed ID: 29970615
[TBL] [Abstract][Full Text] [Related]
5. Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.
van der Hoeven D; Cho KJ; Ma X; Chigurupati S; Parton RG; Hancock JF
Mol Cell Biol; 2013 Jan; 33(2):237-51. PubMed ID: 23129805
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of K-Ras plasma membrane localization.
Cho KJ; van der Hoeven D; Hancock JF
Enzymes; 2013; 33 Pt A():249-65. PubMed ID: 25033808
[TBL] [Abstract][Full Text] [Related]
7. Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling.
Kovar SE; Fourman C; Kinstedt C; Williams B; Morris C; Cho KJ; Ketcha DM
Bioorg Med Chem Lett; 2020 Jun; 30(11):127144. PubMed ID: 32276831
[TBL] [Abstract][Full Text] [Related]
8. 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.
Mohammed I; Hampton SE; Ashall L; Hildebrandt ER; Kutlik RA; Manandhar SP; Floyd BJ; Smith HE; Dozier JK; Distefano MD; Schmidt WK; Dore TM
Bioorg Med Chem; 2016 Jan; 24(2):160-78. PubMed ID: 26706114
[TBL] [Abstract][Full Text] [Related]
9. Structures, Biosynthesis, and Bioactivity of Oligomycins from the Marine-Derived
Feng XY; Li JH; Li RJ; Yuan SZ; Sun YJ; Peng XP; Dong H; Lou HX; Li G
J Agric Food Chem; 2024 Jan; 72(2):1082-1095. PubMed ID: 38169320
[TBL] [Abstract][Full Text] [Related]
10. Selective growth inhibition by suppression of F1Fo ATPase in canine malignant melanoma cell lines.
Kuroki S; Kobayashi M; Tani H; Miyamoto R; Kurita S; Tamura K; Ono K; Washizu T; Bonkobara M
J Vet Pharmacol Ther; 2017 Jan; 40(1):101-104. PubMed ID: 27292541
[TBL] [Abstract][Full Text] [Related]
11. Study on retroaldol degradation products of antibiotic oligomycin A.
Lysenkova LN; Turchin KF; Korolev AM; Danilenko VN; Bekker OB; Dezhenkova LG; Shtil AA; Preobrazhenskaya MN
J Antibiot (Tokyo); 2014 Feb; 67(2):153-8. PubMed ID: 24084683
[TBL] [Abstract][Full Text] [Related]
12. A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A.
Lysenkova LN; Turchin KF; Korolev AM; Bykov EE; Danilenko VN; Bekker OB; Trenin AS; Elizarov SM; Dezhenkova LG; Shtil AA; Preobrazhenskaya MN
J Antibiot (Tokyo); 2012 Aug; 65(8):405-11. PubMed ID: 22617550
[TBL] [Abstract][Full Text] [Related]
13. Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.
Lysenkova LN; Saveljev OY; Grammatikova NE; Tsvetkov VB; Bekker OB; Danilenko VN; Dezhenkova LG; Bykov EE; Omelchuk OA; Korolev AM; Shchekotikhin AE
J Antibiot (Tokyo); 2017 Jul; 70(8):871-877. PubMed ID: 28420869
[TBL] [Abstract][Full Text] [Related]
14. Vimentin and the K-Ras-induced actin-binding protein control inositol-(1,4,5)-trisphosphate receptor redistribution during MDCK cell differentiation.
Dingli F; Parys JB; Loew D; Saule S; Mery L
J Cell Sci; 2012 Nov; 125(Pt 22):5428-40. PubMed ID: 22946050
[TBL] [Abstract][Full Text] [Related]
15. Boron-based inhibitors of acyl protein thioesterases 1 and 2.
Zimmermann TJ; Bürger M; Tashiro E; Kondoh Y; Martinez NE; Görmer K; Rosin-Steiner S; Shimizu T; Ozaki S; Mikoshiba K; Watanabe N; Hall D; Vetter IR; Osada H; Hedberg C; Waldmann H
Chembiochem; 2013 Jan; 14(1):115-22. PubMed ID: 23239555
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and properties of a novel brominated oligomycin A derivative.
Lysenkova LN; Turchin KF; Korolev AM; Danilenko VN; Bekker OB; Trenin AS; Shtil AA; Preobrazhenskaya MN
J Antibiot (Tokyo); 2012 Apr; 65(4):223-5. PubMed ID: 22318333
[No Abstract] [Full Text] [Related]
17. Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling.
Garrido CM; Henkels KM; Rehl KM; Liang H; Zhou Y; Gutterman JU; Cho KJ
Sci Rep; 2020 Jun; 10(1):9120. PubMed ID: 32499517
[TBL] [Abstract][Full Text] [Related]
18. Oligomycin F, a new immunosuppressive homologue of oligomycin A.
Laatsch H; Kellner M; Wolf G; Lee YS; Hansske F; Konetschny-Rapp S; Pessara U; Scheuer W; Stockinger H
J Antibiot (Tokyo); 1993 Sep; 46(9):1334-41. PubMed ID: 8226311
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions.
Tamanoi F; Lu J
Enzymes; 2013; 34 Pt. B():181-200. PubMed ID: 25034105
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
